Centaurus Financial’s DermTech, Inc. Common Stock DMTK Stock Holding History

Centaurus Financial’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,806	Closed	-$246K	–	930
2023 Q1	$246K	Buy	66,806 +14,050	+27%	+$59.2K	0.02%	607
2022 Q4	$93K	Buy	52,756 +9,940	+23%	+$26.4K	0.01%	808
2022 Q3	$170K	Buy	42,816 +400	+0.9%	+$2.46K	0.02%	662
2022 Q2	$235K	Sell	42,416 -2,630	-6%	-$21.5K	0.02%	557
2022 Q1	$661K	Buy	45,046 +2,977	+7%	+$39.8K	0.05%	356
2021 Q4	$665K	Sell	42,069 -8,405	-17%	-$202K	0.05%	369
2021 Q3	$1.62M	Sell	50,474 -542	-1%	-$19K	0.14%	184
2021 Q2	$2.12M	Buy	51,016 +15,740	+45%	+$647K	0.18%	145
2021 Q1	$1.79M	Buy	+35,276	New	+$1.85M	0.18%	149

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Centaurus Financial's DMTK Position: Q2 2023 in Review

Centaurus Financial sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 66,806 shares — an estimated $246K sold.

Centaurus Financial first reported a position in DMTK in Q1 2021 and held it in 9 quarters. The position peaked at $2.12M in Q2 2021. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

Centaurus Financial reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Centaurus Financial sold 66,806 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $246K.
Centaurus Financial first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Centaurus Financial's DermTech, Inc. Common Stock position peaked at $2.12M in Q2 2021.
85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Centaurus Financial's 13F filing for Q2 2023, filed 15 Aug 2023.